Clinical Trial Update: Perspectives of Subcutaneous Velcade at Home of Patients With Myeloma.

View source ↗

Summary

This clinical trial update discusses patient perspectives on home-based, subcutaneous Velcade (bortezomib) for multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Velcade (bortezomib)

Snippet

Sponsor: Karin B. Ø. Dieperink | Conditions: Multiple Myeloma | Status: COMPLETED